Table 2. Anaplastic thyroid carcinomas (ATC)–clinical and CGH data.

Case	Sex/age	CGH results
1	F/51	−13
2	F/77	−1pter–p13, +2, −3pter–p14, +3p12.1–qter*, −4q10–qter, +5p13–qter, +6pter–p10, +7pter–q22, −8pter–p23, +8q10–qter, +9pter–p13*, +9p11–q12, +9q33–qter, −10pter–p11.2, +11q12–q13, −11q14.3–q23.2, +12pter–q12*, +16q10–q11.2, +16q21–qter, −17p13.1–p11.2, −18, +19p13.2, +20, −Xpter–p10
3	F/74	+1pter–p13, +3pter–p23, +3p11.2–qter, +4q10–qter, +5, −7q22–q32, +11pter–p12, +13q34–qter, +14q12–qter, +18p11.1–qter*, +19q12–q13.1, +19q13.3, +20, −Xpter–Xq22
4	F/72	+1pter–p36, +1p35, +1p32, +1p31.1–p22, −2q33–qter, +3q26–qter, −4q33–qter, +5pter–p10*, +7pter–p21, −7q31, +9pter–p24, −9p21–p12, −12pter–p11.1, −13q10–q21, +14q10–qter*, +15q21–qter, +19p12.1, +19q13.2, +20, −Xpter–p11.1, −Xq10–qter
5	F/66	+1pter–p13, +1q12–q21, +1q25–qter, +2p23–p15, +2q14.1–q24, −3pter–p25, +3q11.2–qter, +4pter–4q31.3, +5pter–q33, +6p23–q15*, +6q22, +7pter–p21, −7q10–qter, +8q10–qter, −9pter–p24, +10pter–p11.2, +11q12, −11q14–qter, −12p12, +12q14–q21.3, +14q10–qter, +15q10–qter, +16q10–qter, −17p12–p11, +17q22–qter, −18p11–qter, +19p13.1–p11.2, +20p11–qter, +21q21.2–qter, −X
6	F/77	−2pter–p24, +2q23–q32, +2q33.2–q35, −3p14–p12, +4p15.2–q32, +5p11–qter, +7q22–q34, −8pter–p12, +8q10–qter, −9pter–p21, +9q22–qter, +10, +12pter–p11, −12q15–qter, −13q12–q31, −15q10–qter, −17pter–p11, −17q11–q22, +20p11.2–qter, +21q21.1–qter, +22q11–qter, −Xpter–p11.2
7	F/64	+1pter–p13, −2q33, +3q27, −4q33–qter, −5q13–q21, +9pter–p22, +9q22–qter, +10q24–qter, +12pter–p13, −13q21–q33, +14q32–qter, +17, +19pter–p10, +20p11–qter, −21q11.2–q21, +22q12–qter, −Xp11.2–q13.

F=female; M=male;

^*in bold–regions where high amplifications were observed.